Author

Alexander V. Sherman

Observed names: A. Sherman, Alex V. Sherman

Institutions: Harvard University, Massachusetts General Hospital, Mass General Brigham

Observed institutions: Harvard University, Massachusetts General Hospital, Mass General Brigham

ORCID: 0000-0003-2097-5289

Observed ORCID: 0000-0003-2097-5289

OpenAlex ID: A5059218397

Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial

2025 · Brittney A. Harkey, Sofia Distefano, et al. · Muscle & Nerve · 11

Access for ALL in ALS: A large‐scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis

2024 · James D. Berry, Sabrina Paganoni, et al. · Muscle & Nerve · 9

The natural history of ALS: Baseline characteristics from a multicenter clinical cohort

2023 · Alex Berger, Matteo Locatelli, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 9

Toward therapeutic trials in primary lateral sclerosis

2025 · Erica Scirocco, Matti D. Allen, et al. · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 6

An Automated Listener-Effort Measure for ALS Generalizes across Diverse Platforms and Protocols

2026 · Esteban G. Roitberg, Marcos A. Trevisan, et al. · Research Square

At‐Home Versus in‐Clinic Vital Capacity Measurement: Insights From the HEALEY ALS Platform Trial

2026 · Eric A. Macklin, James D. Berry, et al. · Muscle & Nerve

Evaluating Metformin Efficacy in ALS Using Real-World Data: A Causal Inference Approach

2026 · Julia A. Geller, Alex Berger, et al. · medRxiv

Platform for Clinical Trials Data Integration and Sharing as a Unique Industry, Academic, and Foundation Collaboration Resource in ALS Research (P01.091)

2012 · A. Sherman, M. Leitner, et al. · Neurology

Works count: 8

Citation count: 35

H-index: 4

I10-index: 1